PCN Insights, News, Videos, and More

Patients with major depressive disorder (MDD) reported feeling calmer and more engaged after treatment with adjunctive brexpiprazole, according to a poster presented at Psych Congress 2020.

The use of MDMA-assisted psychotherapy for the treatment of PTSD could receive final approval by the FDA by 2022, Rick Doblin, PhD, of the Multidisciplinary Association for Psychedelic Studies told Psych Congress 2020 preconference attendees.

BLOG: Psychedelic-assisted therapies, once consigned to the fringes of psychiatric practice, are exploding into the mainstream of psychiatry and will take center stage at a Psych Congress preconference.

​​​​​​​Cannabis use is significantly growing among US adults with depression, who have approximately double the odds of cannabis use compared with adults without depression.

Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.

Attention-deficit/hyperactive disorder (ADHD) and narcolepsy may share genetic links, according to an analysis of polygenic risk scores published online in the journal Translational Psychiatry.